Problems in assessment of new pharmacologic agents for the heart failure patient.

[1]  E. J. Brown,et al.  Acute Effects of Oral Pirbuterol on Myocardial Oxygen Metabolism and Systemic Hemodynamics in Chronic Congestive Heart Failure , 1981, Circulation.

[2]  B. Tandon.  A COORDINATED APPROACH TO CHILDREN'S HEALTH IN INDIA INTEGRATED CHILD DEVELOPMENT SERVICE , 1981, The Lancet.

[3]  E. Amsterdam,et al.  Hemodynamic Effects of Oral Pirbuterol in Chronic Severe Congestive Heart Failure , 1981, Circulation.

[4]  E. Braunwald,et al.  Effects of amrinone on experimental acute myocardial ischaemic injury. , 1980, Cardiovascular research.

[5]  E. Braunwald,et al.  Effects of Amrinone on Myocardial Energy Metabolism and Hemodynamics in Patients with Severe Congestive Heart Failure Due to Coronary Artery Disease , 1980, Circulation.

[6]  E. Braunwald,et al.  Oral amrinone in refractory congestive heart failure. , 1980, The American journal of cardiology.

[7]  D. Mason,et al.  Comparative effects of oral pirbuterol versus intravenous dobutamine on left ventricular function and energetics in chronic congestive heart failure: Unique advantage of pirbuterol due to vasodilator and inotropic properties , 1980 .

[8]  E. Braunwald,et al.  Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.

[9]  G. Y. Lesher,et al.  Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.

[10]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[11]  E. Sonnenblick,et al.  Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.

[12]  E. Sonnenblick,et al.  Amrinone A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man , 1979, Circulation.

[13]  J. Franciosa,et al.  Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.

[14]  J A Parker,et al.  Regional Ejection Fraction A Quantitative Radionuclide Index of Regional Left Ventricular Performance , 1979, Circulation.

[15]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[16]  E. Sonnenblick,et al.  Dobutamine: a new synthetic cardioactive sympathetic amine. , 1979, The New England journal of medicine.

[17]  E. Braunwald,et al.  Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.

[18]  C. Leier,et al.  Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure , 1978, Circulation.

[19]  W. Aronow,et al.  Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure. , 1978, The American journal of medicine.

[20]  W. Grossman,et al.  Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response. , 1978, The American journal of medicine.

[21]  A. Alousi,et al.  New cardiotonic agents: a search for digitalis substitute. , 1978, Life sciences.

[22]  S. Ayres,et al.  Effect of Dopamine on Hemodynamics and Myocardial Metabolism in Shock Following Acute Myocardial Infarction in Man , 1978, Circulation.

[23]  E. Braunwald.  Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.

[24]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[25]  R R Miller,et al.  Combined Dopamine and Nitroprusside Therapy in Congestive Heart Failure: Greater Augmentation of Cardiac Performance by Addition of Inotropic Stimulation to Afterload Reduction , 1977, Circulation.

[26]  W. Grossman,et al.  Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations. , 1977, The Journal of clinical investigation.

[27]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[28]  R. Miller,et al.  Pharmacological Mechanisms for Left Ventricular Unloading in Clinical Congestive Heart Failure: Differential Effects of Nitropmsside, Phentolamine, and Nitroglycerin on Cardiac Function and Peripheral Circulation , 1976, Circulation research.

[29]  R. Russell,et al.  Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. , 1976, The American journal of cardiology.

[30]  E. Amsterdam,et al.  Hemodynamic effects of nitroglycerin in acute myocardial infarction. , 1975, Circulation.

[31]  L. I. Goldberg,et al.  Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.

[32]  J. Cohn,et al.  IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION , 1972 .

[33]  S. Ayres,et al.  Effect of Isoproterenol, l‐Norepinephrine, and Intraaortic Counterpulsation on Hemodynamics and Myocardial Metabolism in Shock following Acute Myocardial Infarction , 1972, Circulation.

[34]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.

[35]  E. Braunwald,et al.  Control of myocardial oxygen consumption: physiologic and clinical considerations. , 1971, The American journal of cardiology.

[36]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[37]  D T Mason,et al.  Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man. , 1969, The American journal of cardiology.

[38]  J. Mitchell,et al.  Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. , 1963, The American journal of physiology.